US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

102.50

-0.7073-0.69%

Post-market: 102.36-0.1428-0.14%19:30 EDT

Volume:18.72K

Turnover:1.92M

Market Cap:128.12M

PE:- -

High:103.87

Open:103.87

Low:102.00

Close:103.21

52wk High:110.05

52wk Low:70.27

Shares:1.25M

Float Shares:1.25M

Volume Ratio:1.09

T/O Rate:1.50%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Press Release: Celcuity Appoints David Gryska to Its Board of Directors

Abogen announces licensing, option agreement with Novartis

The Hidden Silver Lining of High Interest Rates: Safer, Cheaper Retirement Income

Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase

How are higher interest rates and rising prices affecting you?

Unconventional wisdom: Four assumptions for building wealth that investors should revisit

Morning Star AU

Oxford BioDynamics Extends Vulpes Payment Deadline in £9.15m Placing

AEON Biopharma advances ABP-450 biosimilar development strategy

Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations

Lonza Strengthens Board with Nomination of Biotech Veteran Pearl Huang

Actinogen Medical Adds Modest Number of New Shares to ASX Listing

Mayne Pharma Secures Long-Term IMVEXXY Patent Protection in U.S. Settlement With Sun Pharma

Marvel Biosciences Raises $1.6 Million to Advance Lead Neurology Drug Into Phase 1 Trials

Economists warn house prices to fall after latest rate riseAustralia's housing market is in for a hiding from higher interest rates, lower borrowing capacity and tax changes.2 min read

Swiss Franc Falls Sharply on Prospect of Global Monetary Policy Tightening

Rhythm Biosciences Files Updated Corporate Governance Statement With ASX

Sandoz boosts European biosimilar capacity with new Slovenian plant

Teva announces FDA approval of Degevma as a biosimilar to Xgeva

Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)

SpareBank 1 Nord-Norge lifts loan and deposit rates after Norges Bank hike

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BBP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":102.4978,"timestamp":1790971200000,"preClose":103.2051,"halted":0,"volume":18715,"hourTrading":{"tag":"盘后","latestPrice":102.355,"preClose":102.4978,"latestTime":"19:30 EDT","volume":12,"amount":1229.9736,"timestamp":1790983804639,"change":-0.1428,"changeRate":-0.001393,"amplitude":0},"delay":0,"changeRate":-0.0068533434878703045,"floatShares":1250004,"shares":1250004,"eps":0,"marketStatus":"Market Closed","change":-0.7073,"latestTime":"10-02 16:00:00 EDT","open":103.87,"high":103.87,"low":102.0005,"amount":1918982.2008,"amplitude":0.018114,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":103.2051,"sharesOutstanding":600004,"nav":102.494,"aum":128117601.53,"bidAskSpread":0.002439,"postHourTrading":{"tag":"盘后","latestPrice":102.355,"preClose":102.4978,"latestTime":"19:30 EDT","volume":12,"amount":1229.9736,"timestamp":1790983804639,"change":-0.1428,"changeRate":-0.001393,"amplitude":0},"volumeRatio":1.0888030521127026,"impliedVol":0.2277,"impliedVolPercentile":0.4462},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1250004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.0888030521127026,"shares":1250004,"dividePrice":0,"high":103.87,"amplitude":0.018114,"preClose":103.2051,"low":102.0005,"week52Low":70.27,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":102.4978,"eps":0,"divideRate":0,"volume":18715,"delay":0,"ttmEps":0,"open":103.87,"prevYearClose":79.9149,"prevWeekClose":104.6582,"prevMonthClose":105.5872,"prevQuarterClose":105.5872,"fiveDayClose":104.6582,"twentyDayClose":108.8566,"sixtyDayClose":103.6198},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672116477","title":"Press Release: Celcuity Appoints David Gryska to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672116477","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672116477?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:00","pubTimestamp":1790942400,"startTime":"0","endTime":"0","summary":"MINNEAPOLIS, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid tu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","CELC","NVIB","IDNA","BK4139","BK4555","HYLG","RSPH","IEIH","BK4099","GDOC","MEDX","BBP","BK4588","SYNB","TM","BK4585","03160","BK4604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672163957","title":"Abogen announces licensing, option agreement with Novartis","url":"https://stock-news.laohu8.com/highlight/detail?id=2672163957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672163957?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:10","pubTimestamp":1790935812,"startTime":"0","endTime":"0","summary":"Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, announced that it has entered into a licensing and option agree...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abogen-announces-licensing-option-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abogen-announces-licensing-option-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","FHLC","AGNG","BBP","BBC","SYNB","XT","JDOC","BK4588","LNGR","IBB","BK4585","BK4139","RSPH","FWD","IEIH","RNA","IE0009354923.USD","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672945767","title":"The Hidden Silver Lining of High Interest Rates: Safer, Cheaper Retirement Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2672945767","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672945767?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:27","pubTimestamp":1790890020,"startTime":"0","endTime":"0","summary":"Annuity payout rates are closely tied to interest ratesHigher interest rates also mean that it takes less to secure the same retirement standard of living as before rates started rising.It's an ill wi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRSH","TSDD","UCC","DFUV","TSYY","DFIP","TSLR","STOT","TSLO","TSLP","DRKY","TESL","XYLD","VAW","KOMP","CAOS","LJAN","PEVC","HIGH","BALQ","LRCY","FXL","PAYM","IJK","THY","TSII","CLIX","TSLI","QYLG","RJZ","YLD","ANEW","SETM","TSLG","XYLG","AVSD","BUCK","LIAO","IBIB","LCTO","MDIV","LIAJ","BBP","TSLQ","CGDV","LIBD","WIA","CEFD","FXR","HIPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672629967","title":"Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2672629967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672629967?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:37","pubTimestamp":1790887025,"startTime":"0","endTime":"0","summary":"The latest update is out from Nanobiotix ( ($FR:NANO) ). Nanobiotix is a late‑stage French biotechnology company developing physics‑based therapeut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","FHLC","JDOC","SYNB","IEIH","XBIX","AGNG","FWD","BBP","IBB","BK4588","NANO","NVIB","RSPH","DARP","BK4585","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672012761","title":"How are higher interest rates and rising prices affecting you?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672012761","media":"CNN Business","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672012761?lang=en_us&edition=fundamental","pubTime":"2026-10-02 02:41","pubTimestamp":1790880103,"startTime":"0","endTime":"0","summary":"Last month, the Federal Reserve raised interest rates for the first time in more than three years, as it tries to bring inflation under control. But higher rates make borrowing more expensive for consumers and businesses — one reason mortgage rates have climbed to a three-year high in recent weeks.It could take time before consumers see much relief from rising prices. And more rate hikes could be on the way, too.If you’re feeling the squeeze both from higher prices and higher borrowing costs, we want to hear from you.Please fill out the below form for possible inclusion in a CNN story.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"cnn_highlight","url":"https://edition.cnn.com/2026/10/01/economy/interest-rates-inflation-impact-callout","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://edition.cnn.com/2026/10/01/economy/interest-rates-inflation-impact-callout","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cnn_highlight","symbols":["LRCY","TSDD","AVSD","ELOL","TSLQ","DFUV","TESC","ANEW","TSLW","IJK","TSLP","RWVG","07366","DFND","PEX","CLIX","TSLS","07766","BK4588","KOMP","FXR","PEVC","TESL","FXL","09366","TSL","09766","TSLI","BBP","TSII","TSLR","TSLT","RJZ","TSLL","TSLG","TLA","CRSH","TEST","TSLO","VAW","BK4585","TSLZ","QOWZ","TSLY","UCC","CGDV","TSYY","CAOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672919237","title":"Unconventional wisdom: Four assumptions for building wealth that investors should revisit","url":"https://stock-news.laohu8.com/highlight/detail?id=2672919237","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672919237?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:00","pubTimestamp":1790870400,"startTime":"0","endTime":"0","summary":"Conventional wisdom is a byproduct of groupthink that presents solutions good enough for the average person while simultaneously not being right for any individual. You follow it at your peril. Each M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/insights/personal-finance/4STM6WACG5FK3EYWUYFBQJOV3U/unconventional-wisdom-four-assumptions-building-wealth-that-investors-should-revisit","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/insights/personal-finance/4STM6WACG5FK3EYWUYFBQJOV3U/unconventional-wisdom-four-assumptions-building-wealth-that-investors-should-revisit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["ANEW","IMCG","MAPP","FXR","EQRR","IJK","CLIX","FLV","FXL","PRVS","SAMT","TSLP","PEVC","CGUS","BKDV","ILCV","KOMP","AVSD","RMIF","TEQI","DFUV","RULE","RHTX","BBP","REGL","BAMA","VAW","MDLV","LCG","EES","FT","HIDV","VGB.AU","CGDV","LGH","DIVZ","ARP","CDC","SDOG","VOTE","UCC","FXD","BSR","CAOS","IUS","ADPV","PSC","CGUI","DECU","MODL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672632267","title":"Oxford BioDynamics Extends Vulpes Payment Deadline in £9.15m Placing","url":"https://stock-news.laohu8.com/highlight/detail?id=2672632267","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672632267?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:12","pubTimestamp":1790867579,"startTime":"0","endTime":"0","summary":"Oxford BioDynamics ( ($GB:OBD) ) has provided an announcement. Oxford BioDynamics Plc, a 3D genomics-focused biotechnology company listed on AIM, p...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oxford-biodynamics-extends-vulpes-payment-deadline-in-9-15m-placing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oxford-biodynamics-extends-vulpes-payment-deadline-in-9-15m-placing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","DARP","PBE","LNGR","BK4202","BK4585","BMED","IEIH","JDOC","SYNB","XT","GNMX","IBB","BBP","TARK","RSPH","BK4588","AGNG","OXM","GNOM","FHLC","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671204277","title":"AEON Biopharma advances ABP-450 biosimilar development strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2671204277","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671204277?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:34","pubTimestamp":1790771650,"startTime":"0","endTime":"0","summary":"AEON Biopharma ( ($AEON) ) has shared an update. On September 30, 2026, AEON Biopharma announced it had received official minutes from its Biosimil...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aeon-biopharma-advances-abp-450-biosimilar-development-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aeon-biopharma-advances-abp-450-biosimilar-development-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","AEON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671462201","title":"Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations","url":"https://stock-news.laohu8.com/highlight/detail?id=2671462201","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671462201?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:00","pubTimestamp":1790766000,"startTime":"0","endTime":"0","summary":"SINGAPORE and NORTH BRUNSWICK, N.J., Sept.  30, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Group Ltd. (NASDAQ: ANL) (“Adlai Nortye” or the “Company”), a clinical-stage biotechnology company focused on the ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/30/3371738/0/en/adlai-nortye-appoints-christopher-liu-pharmd-as-head-of-investor-relations-and-public-relations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANL","BK4605","LU1861219969.SGD","FHLC","LU1861220033.SGD","LU1861214812.USD","ALN","LU1720051017.SGD","LU1978683503.SGD","ONG","BBP","ONX","LU1720051108.HKD","LU1861215975.USD","SYNB","LU2360107325.USD","JDOC","IE00BFMHRM44.USD","BK4588","IE00BD6J9T35.USD","LU1983260115.SGD","IBB","LU2298322129.HKD","LU0124384867.USD","ON","BK4585","LU1854104046.USD","BK4139","IE00BZ199S13.USD","LU1854103824.USD","BK4512","RSPH","IEIH","LU2357305700.SGD","BK4141","LU0724618433.USD","LU1548497426.USD","LU0348723411.USD","LU2133065610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671278331","title":"Lonza Strengthens Board with Nomination of Biotech Veteran Pearl Huang","url":"https://stock-news.laohu8.com/highlight/detail?id=2671278331","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671278331?lang=en_us&edition=fundamental","pubTime":"2026-09-30 13:32","pubTimestamp":1790746351,"startTime":"0","endTime":"0","summary":"The latest update is out from Lonza Group Ltd ( ($CH:LONN) ). Lonza has nominated pharmaceutical and biotechnology veteran Pearl Huang as an indepe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lonza-strengthens-board-with-nomination-of-biotech-veteran-pearl-huang?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lonza-strengthens-board-with-nomination-of-biotech-veteran-pearl-huang?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","RSPH","BK4588","XT","AGNG","FWD","XBI","SYNB","BK4585","IEIH","JDOC","FHLC","IBB","BBP","LNGR","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671222612","title":"Actinogen Medical Adds Modest Number of New Shares to ASX Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2671222612","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671222612?lang=en_us&edition=fundamental","pubTime":"2026-09-30 11:17","pubTimestamp":1790738242,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) has provided an announcement. Actinogen Medical Limited, an ASX-listed biotechnology company, has its ordinary full...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-adds-modest-number-of-new-shares-to-asx-listing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-adds-modest-number-of-new-shares-to-asx-listing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","IEIH","RSPH","FHLC","DARP","BK4585","LNGR","SYNB","AGNG","FWD","JDOC","BK4588","IBB","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671225700","title":"Mayne Pharma Secures Long-Term IMVEXXY Patent Protection in U.S. Settlement With Sun Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671225700","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671225700?lang=en_us&edition=fundamental","pubTime":"2026-09-30 08:23","pubTimestamp":1790727798,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group ( ($AU:MYX) ) just unveiled an announcement. Mayne Pharma has settled U.S. Paragraph IV patent litigation with Sun Pharmaceutica...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mayne-pharma-secures-long-term-imvexxy-patent-protection-in-u-s-settlement-with-sun-pharma?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mayne-pharma-secures-long-term-imvexxy-patent-protection-in-u-s-settlement-with-sun-pharma?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXTI","RND","MEDX","USRD","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671122851","title":"Marvel Biosciences Raises $1.6 Million to Advance Lead Neurology Drug Into Phase 1 Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2671122851","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671122851?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:32","pubTimestamp":1790721144,"startTime":"0","endTime":"0","summary":"An update from Marvel Biosciences Corp ( ($TSE:MRVL) ) is now available. Marvel Biosciences Corp., a Calgary-based pre-clinical biotechnology compa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/marvel-biosciences-raises-1-6-million-to-advance-lead-neurology-drug-into-phase-1-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/marvel-biosciences-raises-1-6-million-to-advance-lead-neurology-drug-into-phase-1-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","LNGR","BK4585","BK4588","DBB","RSPH","XT","DARP","BBP","SYNB","FWD","IEIH","JDOC","FHLC","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671522015","title":"Economists warn house prices to fall after latest rate riseAustralia's housing market is in for a hiding from higher interest rates, lower borrowing capacity and tax changes.2 min read","url":"https://stock-news.laohu8.com/highlight/detail?id=2671522015","media":"7NEWS","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671522015?lang=en_us&edition=fundamental","pubTime":"2026-09-30 00:00","pubTimestamp":1790697600,"startTime":"0","endTime":"0","summary":"House prices are now likely to fall further and for longer than they have in previous property market downturns, according to economists.The forebodings came soon after the Reserve Bank of Australia (","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"7news_stock","url":"https://7news.com.au/news/economists-warn-plummeting-house-prices-on-the-cards-as-increased-cash-rate-squeezes-buyers-c-22946265","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://7news.com.au/news/economists-warn-plummeting-house-prices-on-the-cards-as-increased-cash-rate-squeezes-buyers-c-22946265","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"7news_stock","symbols":["TESL","ELOL","DFND","FXR","07366","RBA","EFC-B","07766","TESC","IJK","RWVG","TSDD","QOWZ","TLA","ANEW","KOMP","TSLP","FXL","CRSH","BK4585","RJZ","VABS","CLIX","CAOS","PEVC","LRCY","TSLY","TEST","TSLL","TSLS","TSLW","UCC","TSLO","TSLI","TSYY","TSLZ","TSLQ","AVSD","TSLT","TSLG","BBP","TSLR","CGDV","TSII","VAW","09366","DFUV","TSL","PEX","09766"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671299424","title":"Swiss Franc Falls Sharply on Prospect of Global Monetary Policy Tightening","url":"https://stock-news.laohu8.com/highlight/detail?id=2671299424","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671299424?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:17","pubTimestamp":1790666220,"startTime":"0","endTime":"0","summary":"0717 GMT - The Swiss franc falls to a 16-month low against the dollar and an 11-day low versus the euro. The franc continues to be hit by prospect of the Swiss National Bank keeping interest rates at 0% while peers, including the U.S. Federal Reserve, raise interest rates in response to rising oil prices due to the Middle East conflict. \"The franc's weakness appears a more structural problem at this stage,\" ING's Francesco Pesole says in a note. The dollar rises to as high as 0.8339 francs and ING sees it reaching 0.84-0.85 if the Fed raises interest rates in October. The euro rises to as high as 0.9471 francs.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGDV","TSLP","VAW","KOMP","BBP","UCC","AVSD","FXR","LRCY","ANEW","DFUV","RJZ","PEVC","FXL","CAOS","IJK","CLIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671299437","title":"Rhythm Biosciences Files Updated Corporate Governance Statement With ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2671299437","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671299437?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:13","pubTimestamp":1790665987,"startTime":"0","endTime":"0","summary":"An announcement from Rhythm Biosciences Ltd. ( ($AU:RHY) ) is now available. Rhythm Biosciences Ltd., an Australian biotechnology company, operates...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rhythm-biosciences-files-updated-corporate-governance-statement-with-asx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rhythm-biosciences-files-updated-corporate-governance-statement-with-asx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","XT","FWD","LNGR","BK4585","BK4588","BBP","FHLC","JDOC","DARP","IBB","IEIH","SYNB","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671293981","title":"Sandoz boosts European biosimilar capacity with new Slovenian plant","url":"https://stock-news.laohu8.com/highlight/detail?id=2671293981","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671293981?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:32","pubTimestamp":1790659944,"startTime":"0","endTime":"0","summary":"Sandoz Group Ltd ( ($CH:SDZ) ) has provided an update. Sandoz has opened a high-tech, high-volume biosimilar drug substance manufacturing centre in...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sandoz-boosts-european-biosimilar-capacity-with-new-slovenian-plant?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sandoz-boosts-european-biosimilar-capacity-with-new-slovenian-plant?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EES","EPV","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671125702","title":"Teva announces FDA approval of Degevma as a biosimilar to Xgeva","url":"https://stock-news.laohu8.com/highlight/detail?id=2671125702","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671125702?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:05","pubTimestamp":1790625914,"startTime":"0","endTime":"0","summary":"Teva (TEVA) Pharmaceutical Industries announced that the FDA has approved Degevma as a biosimilar to Xgeva. Degevma is indicated for the prevention...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-announces-fda-approval-of-degevma-as-a-biosimilar-to-xgeva-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","MRNX","RSPH","BK4559","BK4584","GNMX","TEVA","LFSC","XLVX","PINK","NVIB","SYNB","MRNY","BK4557","IBB","IYH","BK4596","PSCH","BK4588","MEDI","GDOC","BK4007","TECB","LU2324357040.USD","IEIH","FRTY","BMED","BK4585","LU1983299246.USD","TBXU","BBP","LABU","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671505252","title":"Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671505252","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671505252?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:00","pubTimestamp":1790625600,"startTime":"0","endTime":"0","summary":"DEGEVMA is now FDA-approved across all indications of the reference product, Xgeva (denosumab), to help prevent bone complications in adults with advanced cancer that has spread to the bone, for the t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/28/3370248/0/en/teva-continues-biosimilar-momentum-with-u-s-fda-approval-of-degevma-denosumab-adet-a-biosimilar-to-xgeva-denosumab.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4156","BBP","LABU","BK4585","BK4588","MVF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670327482","title":"SpareBank 1 Nord-Norge lifts loan and deposit rates after Norges Bank hike","url":"https://stock-news.laohu8.com/highlight/detail?id=2670327482","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670327482?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:09","pubTimestamp":1790597368,"startTime":"0","endTime":"0","summary":"SpareBank 1 Nord-Norge ( ($SPXXF) ) has issued an update. SpareBank 1 Nord-Norge will raise interest rates on both mortgages and deposits by up to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sparebank-1-nord-norge-lifts-loan-and-deposit-rates-after-norges-bank-hike?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sparebank-1-nord-norge-lifts-loan-and-deposit-rates-after-norges-bank-hike?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LRCY","TSLT","VAW","07366","CLIX","TSL","TSLL","BK4585","ENOR","TEST","TESL","TSLI","RJZ","TESC","TSLO","07766","FXL","TSLW","CRSH","DFUV","TSLP","BBP","TSYY","ANEW","09366","TSII","UCC","KOMP","TSLG","CGDV","BK4588","TLA","IJK","TSLQ","TSLY","TSLZ","TSLS","CAOS","ELOL","TSLR","09766","PEVC","AVSD","TSDD","FXR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}